VERSION 1 -AUTHOR RESPONSE
Reviewer 1 1. Probably you are going to find a small number of papers. In this way, why to restrict to RCT?
Response
The authors thank the reviewer for their suggestion to include other types of studies within our systematic review. One of the concerns we have, and anticipate, is that there exists a wide array of NIBS techniques and study designs to evaluate their effects in dexterity; resultantly in order to homogenize the sample we opted to focus only on randomized clinical trials. This is also alluded to with our meta-analytical approach consisting of a random effects model, as mentioned in the data synthesis section (Page. 7, lines 1-7).
"We anticipate the confines of this approach will parallel former systematic reviews and meta-analysis on upper-limb function, for example there will be heterogeneous study design, pathophysiologic variability like different brain architecture between chronic and acute conditions, parameters for stimulation will vary, alternate trial designs will be present and even outcomes will be recorded through different instruments [29, [33] [34] [35] [36] [37] [38] [39] [40] [47] [48] [49] [50] . For this reason, a random effects assumption will be assumed for measuring the pooled data."
Another consideration is that we are using Cochrane's highly sensitive search strategy, which yields a sensitivity of 98% and precision of 13% for randomized clinical trials, reviewing four large databases, and mining articles from the reference of included full-texts. We believe this will bolster the number of RCTs obtained.
Additionally, by using the International Classification of Functioning, Disability and Health (ICF) domains on the outcomes we expect to increase the number of comparisons for the meta-analysis, which should also address this issue. We expect to obtain a substantial number of records and comparisons for review with these strategies, while also benefiting from the rigorous cause-effect design, and standardization of RCTs (1).
2.
Please explain what means that the outcome is not depending on the participant´s or rater´s observation. Are the performances going to be measured in seconds?
Indeed, this refers to the outcomes being measured in seconds or by the number of pegs/blocks placed, instead of through the rater's professional interpretation, which is often used in other scales (For example, the Wolf Motor Function Test in addition to using timed, continuous variables also includes an ordinal variable for classifying patients which is dependent on the reviewers interpretation of function. [See: http://www.rehabmeasures.org/Lists/RehabMeasures/DispForm.aspx?ID=927])
To clarify this point we added these specifications in the manuscript. It now reads:
"These outcomes will be continuous, and not dependent on the participant´s or rater´s observation (that is they will be measured in seconds, or number of blocks/pegs placed, and not by an individual's interpretation)." (Page 3, lines 27/28).
Finally, we thank reviewer 1 again for their recommendations and hope we addressed their questions in whole. Reviewer 2 1. I have reviewed the protocol and do not have major comments, the only two minor comments are the following: " p. 6 among the parameters of non-invasive brain stimulation I would suggest to also include for the tDCS besides the current intensity (that is generally reported in the papers) the size/area of the electrodes and/or alternatively the current density. This is a very important parameter especially in relation to safety issues.
We agree with the reviewer's suggestion and have now added these parameters to our data extraction section and have adapted the manuscript as follows (highlighted in yellow): "Data will be extracted into a custom spreadsheet which will incorporate at the following: […] 5) Parameters of non-invasive brain stimulation will be noted (For example: montage, site of stimulation, current intensity, electrode size, current density, duration of stimulation, polarity, number of pulses, trains, sessions, frequency of pulse, duration of pulse, number of pulses per train, number of trains, number of pulses per session, total number of pulses delivered, %RMT)" (Page 6, lines 35-36).
2. In stroke patients also the areas affected by the lesion (i.e. cortical, subcortical), the extension of the lesion, and the phase/duration of the disease (acute, subacute, chronic), in my opinion, need to be taken into account as variables that might affect the outcome of the brain stimulation treatment.
Similarly, these are important variables and it is our intention to analysis them by sensitivity analysis, as referred to in the following section of the manuscript: "Sensitivity analysis based on pathology, NIBS technique and risk of bias will be done." (Page 7, lines 23-24) However, we also agree that our text is not completely clear and can be interpreted differently. Therefore, we added the following text (highlighted in yellow): "Data will be extracted into a custom spreadsheet which will incorporate at the following: […] 3) Clinical information (for example: Diagnosis and diagnostic criteria, medications, therapy, adverse events, comorbidities, inclusion and exclusion criteria for individual studies, type of lesion and extension, and time since onset in stroke)" (Page 6, lines 31-34).
Again, we thank reviewer 2 for their suggestions and review. We hope to have addressed any concern disclosed. Additional comments Please note that the authors updated the institution of the last author and the funding of the article if accepted. Also as per request of the Editor we removed the PROSPERO link and only included the number. These changes can be found on the first page, second page and page 8 of the manuscript.
